Neumora Therapeutics, Inc 10-Q for FY2025 Q2
Neumora Therapeutics, Inc. (NMRA)
10-Q
2025-08-06
For: 2025-06-30
View Original
Added on
April 06, 2026
About this 10-Q
Neumora Therapeutics, Inc filed this 10-Q on August 6, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).
Headline figures
Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $52.73M
- compared with a net loss of $58.7M a year earlier
- Diluted EPS
- -$0.33
- compared with -$0.37 a year earlier